Browse Category:

Categories

[Search within category]

Safe and Effective Dermal Decontamination Gel

This novel dermal gel formulation is an easy and highly effective method for removing and reducing absorption of skin contaminants.

Diagnostic and Screening Methods for Atopic Dermatitis

Atopic dermatitis (AD) is a chronic itch and inflammatory disorder of the skin that affects one in ten people. Patients suffering from severe AD eventually progress to develop asthma and allergic rhinitis, in a process known as the “atopic march.” Signaling between epithelial cells and innate immune cells via the cytokine Thymic Stromal Lymphopoietin (TSLP) is thought to drive AD and the atopic march. TSLP is up regulated in atopic dermatitis patients and is thought to act on immune cells to trigger atopic dermatitis. Scientists at UC Berkeley discovered that TSLP also activates a subset of sensory neurons to signal itch by acting on TSLPR, which signals to TRPA1. They demonstrated that sensory neurons that transmit itch signals in AD are the only instance of signaling between TSLPR and TRPA1 in the same cell type. Therefore, blocking the signaling between TSLPR and TRPA1 is a novel and specific target for therapeutics for itch in atopic dermatitis. They also discovered that the Orai I/Stim I pathway triggers expression and secretion of TSLP. This pathway has never been directly demonstrated in human primary keratinocytes and has never before been linked to TSLP. Decreasing expression of Orai I or stim I using siRNA, or the downstream transcription factor, NFATc I, significantly attenuates TSLP secretion, as proven in mice studies. Thus inhibition of Orai I/Stim I/NFATc I signaling pathway is a novel target for therapeutics for itch in atopic dermatitis.

Nanoporphyrin Nanoparticles for Combination Phototherapy and Drug Delivery to Infantile Hemangiomas

Researchers at the University of California Davis have developed a novel treatment method that combines photodynamic therapy and the therapeutic compound propranolol using a nanoparticle platform to treat infantile hemangiomas (IH).

Novel Molecular Markers for Acne Diagnosis and Treatment

The Li group at UCLA has defined sets of biomarkers that can be used for the molecular diagnosis of acne, as well as a subtype of acne that is induced by high vitamin B12 levels in the host organism. These novel biomarkers have the potential to definitively differentiate acne from other skin diseases and aid medical practitioners in determining the most effective, personalized treatment for patients. They may also be used to design new treatments for acne.

Hyaluronic Acid-based Gel for Topical and Subcutaneous Applications

A method for producing chemically-crosslinked hydrogels using a biocompatible “click” chemistry for in situ gelation. 

A Transposon Vector From Aedes Aegypti For Use In Vertebrate And Invertebrate Gene Transfer

Background: Therapeutic delivery of genes is a rapidly evolving technique used to treat or prevent a disease at the root of the problem. Another widely used variation of this technique is to insert a transgene into animals and crops for production of desirable proteins. The global transgenic market is currently $24B with annual growth projections of 10%.  Brief Description: UCR Researchers have identified a novel transposon from Aedes aegypti mosquitoes. This mobile DNA sequence can insert itself into various functional genes to either cause or reverse mutations. They have successfully developed a transposon vector system that can be used in both unicellular & multicellular organisms, which can offer notable insight to enhance current transgenic technologies as well as methods of gene therapy.

Knowledge-Based Methods For Cure On Chronic Wounds

Background: An estimated 7M diabetic patients suffer from chronic wounds, costing the US $25B every year. Type II diabetes is on the rise and there is a critical unmet medical need for a treatment that accelerates wound healing. Brief Description: UCR researchers have discovered a groundbreaking antioxidant compound and a sequence of methods that treats chronic wounds. They were able to decrease infection, minimize the production of biofilm, and drastically improve the rate of granulation and re-epithelialization. Existing therapies are unsuccessful in revascularization to normal healing and call for long-term maintenance. This new compound significantly resolves current limitations and can be administered in various ways.

Topical Treatment for Seborrhea (Oily Skin)

Researchers at UC Davis have discovered a compound that shows promise for the topical treatment of oily skin.

Method And Device For Skin Rejuvenation

A method and device for dermatology, cosmetic treatments, skin rejuvenation and scar reduction therapy

Active topical skin protectants using hybrid organic polysilsesquioxane materials

A topical skin protectant formulation containing a barrier cream and an active hybrid organic-inorganic polysilsesquioxane material for protecting warfighters and civilians against all types of harmful chemicals, specifically chemical warfare agents (CWAs).

Exogenous IL-37 Attenuates Inflammation Induced by UVB Radiation and P. Acnes Infection in Human Keratinocytes

Dr. Jenny Kim and colleagues at UCLA have identified a role for anti-inflammatory cytokine involved in balancing the inflammatory response in the skin. This cytokine has the potential to treat inflammation induced by UV radiation or bacterial infection as well as regulating wound healing processes.

In-Plane Ultrasound Needle Guide

A guidance system has been developed to improve ease and accuracy of ultrasound-guided needle placement, with many uses, such as use in peripheral nerve block. Even skilled practitioners still have difficulty maintaining needle tip localization and in-plane needle advancement. The medical device alleviates the challenges of maneuvering and visualizing the needle by fixing the needle in-plane without limiting maneuverability to distal and out-of-the-way targets. For these reasons, the ultrasound needle guide will be an extremely important tool for any needle-based procedure that requires or is augmented by ultrasound guidance; peripheral nerve block procedures in particular. The result is a significant reduction in the potential for complications, increasing patient safety, and reducing block time, while increasing block efficacy.

Shrink-Induced, Self-Driven Microfluidic Devices

The addition of novel surface modifications and use of shrink-wrap film to create devices will yield self-driven, shrink-induced microfluidic detection for samples such as bodily fluids. Novel fabrications and surfaces will have a profound impact on the creation of point of care diagnostics.

Imaging Guided Ablative Laser Surgery

The current method for choosing settings for ablative laser therapy is based on limited information, namely subjective clinician experience and visual assessment of the ablative zone at the treatment site. Researchers at the University of California, Davis have devised an objective real-time method of visualizing the treatment area that will that will allow a laser surgeon to select appropriate ablative laser settings to treat a skin lesions and lesional tissues from other organ systems including, but not limited to: oral mucosa/gingiva, ear/nose and throat, esophagus, gastrointestinal, genitourinary, ophthalmologic and cardiopulmonary.    

Compound for the Prevention Of Rosacea Inflammation

Rosacea is a chronic skin condition characterized by recurrent episodes of flushing, erythema, vasodilation, telangiectasia, edema, papules, pustules, hyperplasia, fibroplasia, itching, burning, pain, and skin tightness. Symptoms of rosacea are exacerbated by sun exposure, hot weather, immersion in hot water, high humidity, sweating, exercise, emotional stress, and spicy food. The skin condition usually begins between the ages of 30 to 50 and occurs more frequently in women than men. An estimated 16 million people are affected by rosacea inflammation in the United States. Oral and topical antibiotics are usually the first line of treatments prescribed for rosacea patients. However, they can cause serious side effects in some patients and do not address the underlying condition. Topical application of steroids may also help alleviate the symptoms, but it can also aggravate the condition. In addition, long term treatments can be inconvenient, lasting for as long as two years.

A Novel Basic Fibroblast Growth Factor Conjugate for Broad Therapeutic Application

UCLA scientists have developed a novel polymer conjugate of basic fibroblast growth factor (bFGF) for use in commercial and possibly clinical applications. This is the first bFGF conjugate to enhance bioactivity and stability under environmental stressors. 

Application of Topical Resveratrol in the Treatment of Acne

Researchers in UCLA Department of Dermatology have demonstrated through in vitro experiments that resveratrol, an ingredient in antioxidants and anti-aging products, generates sustained bactericidal and anti-inflammatory effects against P. acnes, the bacteria involved in the pathogenesis of acne.

Improved Treatment of Keloids and Other Cutaneous Fibrotic Diseases

Researchers at University of California, Davis have discovered that light emitting diode (LED) generated red light and infrared light can modulate skin cell functions associated with skin fibrosis.

Improvement in the treatment of acute and chronic itch.

Researchers at University of California, Davis have discovered a novel combination of drugs that may represent a major improvement in the treatment of acute and chronic itch.

Inflammation Induction and Tissue Repair

Inflammation is an important response for resisting infection and repairing damage. Under circumstances such as cancer or infectious diseases, stimulation of the inflammatory response is therapeutic. It is unclear why the existing adjuvant therapies tend to be more effective in the treatment of some disease, such as breast and colon cancer, than others. This invention identifies additional ways to stimulate the immune response and induce inflammation in order to accelerate repair of disease-related tissue injury.

Diagnostic Markers to Distinguish Between Squamous Cell Carcinoma and Pseudoepitheliomatous Hyperplasia

UCLA scientists have developed a novel diagnostic kit to reliably distinguish squamous cell carcinoma (SCC) from pseudoepitheliomatous hyperplasia (PEH). This fast diagnostic test can replace the non-quantitative and subjective diagnostic methods currently used in hospitals.

Diagnosis and Personalized Acne Therapy

UCLA scientists have discovered novel, bacterial genomic markers that facilitate the personalization of diagnosis and treatment for acne patients.

New Matrices for Cosmetic and Reconstructive Surgery

Decellularization of tissues has recently emerged as a major player in the field of regenerative medicine and offers the possibility of producing a scaffold that closely mimics the physical and chemical cues seen by cells in vivo. Materials produced in this manner often have positive angiogenic and chemoattractant properties. Despite the availability of several injectable materials, there has yet to be identified an engineered material that avoids immune complications and encourages new fat formation. And while many tissues share similar extracellular matrix (ECM) elements, each tissue has its own complex composition and concentration of chemical constituents, which are known to regulate numerous cell processes including attachment, survival, migration, proliferation, and differentiation. There continues to be a need for improved compositions for loose connective tissue repair, regeneration and cell culturing that will closely mimic the complexity of natural adipose extracellular matrix.

Antimicrobial Peptide for the Treatment of Skin Diseases

Granulysin peptides are small antimicrobial agents with potent activity against bacteria and inflammation. A pharmaceutical composition comprising granulysin peptides as an active agent is administered therapeutically to a patient suffering from a microbial infection.

New Light Emission Detection Method Enables High Resolution Optical Imaging of Biological Tissue.

Researchers at the University of California, Irvine have developed a novel method for capturing cellular resolution images of biological tissue at depths of up to several millimeters. Conventional fluorescence detection methods utilize microscope objectives for emission light collection, a less effective approach that is only capable of imaging up to one millimeter deep.To improve upon this standard, the UC researchers minimized light losses by optimizing the system's excitation and detection optics. This new novel method increases the ability to capture cellular resolution images of biological tissues at depths 3x that of previously used methods. The improved method is capable of imaging up to 3 millimeters deep, while previous methods were only capable of depths up to 1 millimeter.

  • Go to Page:

University of California
Innovation Alliances and Services

1111 Franklin Street, 5th Floor,Oakland,CA 94607-5200 |
http://www.ucop.edu/ott/
Tel: 510.587.6000 | Fax: 510.587.6090 | UC.technologies@ucop.edu